Hyman Engelberg
About
In The Last Decade
Hyman Engelberg
83 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 117
- Cardiology and Cardiovascular Medicine 398
- Surgery 262
- Molecular Biology 229
- Cell Biology 214
- Endocrinology, Diabetes and Metabolism 198
Countries citing papers authored by Hyman Engelberg
This map shows the geographic impact of Hyman Engelberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyman Engelberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyman Engelberg more than expected).
Fields of papers citing papers by Hyman Engelberg
This network shows the impact of papers produced by Hyman Engelberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyman Engelberg. The network helps show where Hyman Engelberg may publish in the future.
Co-authorship network of co-authors of Hyman Engelberg
This figure shows the co-authorship network connecting the top 25 collaborators of Hyman Engelberg. A scholar is included among the top collaborators of Hyman Engelberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyman Engelberg. Hyman Engelberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 12 | |
| 3 | 100 | |
| 4 | 8 | |
| 5 | 395 | |
| 6 | 24 | |
| 7 | The effect of cigarette smoking on various clotting time tests. | 2 |
| 8 | 2 | |
| 9 | 24 | |
| 10 | Lipid metabolic studies in patients with essential hypertriglyceridemia. | 8 |
| 11 | 26 | |
| 12 | 11 | |
| 13 | 4 | |
| 14 | 14 | |
| 15 | 7 | |
| 16 | 14 | |
| 17 | 21 | |
| 18 | 3 | |
| 19 | 20 | |
| 20 | Serum lipids and lipoproteins in diabetic glomerulosclerosis. | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.